Table 1.
Individual patient data
| Patient | Group | Age (years) | β Blocker | ACE inhibitor | Other | Notes |
| 1 | A | 48 | L 10 | Amiodarone, statin | B 2.5 added post-CCR | |
| 2* | A | 64 | B 10 | Statin | ||
| 3 | A | 62 | ISMO, statin | |||
| 4 | A | 66 | A 100 | L 5 | ISMO, diltiazem, statin | Nicorandil added at start of CCR |
| 5 | A | 55 | E 2.5 | Statin | Frumil added post-CCR | |
| 6† | A | 63 | M 50 | L 10 | Amiodarone | |
| 7* | A | 54 | C 12.5 | L 10 | Digoxin | |
| 8* | A | 43 | S 40 | |||
| 1 | B | 52 | L 20 | Amiodarone, frusemide | M 25 added at start of CCR | |
| 2 | B | 71 | A 25 | Statin | ||
| 3 | B | 74 | B 5 | L 10 | Bumetanide | |
| 4 | B | 59 | A 50 | |||
| 5* | B | 59 | Amiodarone, bumetanide, losartan | |||
| 6 | B | 67 | L 10 | Amiodarone, bumetanide, statin | ||
| 7 | B | 62 | L 10 | Frusemide | ||
| 8 | B | 34 | S 240 | Ca 12 |
*Did not attend/complete CCR.
†Did not complete 12 week post-CCR exercise test.
Numbers refer to daily doses in mg.
A, atenolol; B, bisoprolol; C, carvedilol; Ca, captopril; CCF, congestive caerdiac failure; CCR, comprehensive cardiac rehabilitation; E, enalapril; Frumil, frusemide + amiloride; ISMO, isosorbide mononitrate; L, lisinopril; M, metoprolol; S, sotalol.